VEGFA and neoplasm: A recent study conducted by Bray and colleagues on a population of 82 dogs indicated the possible use of VEGF and decorin, an angiogenesis inhibitor, as prognostic markers to predict tumor recurrence or dog survival in dogs affected by STSs [54].